Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 695-86-3 | MDL No. : | MFCD01646126 |
Formula : | C5H7N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SEEZTIHVTBTNSZ-UHFFFAOYSA-N |
M.W : | 125.13 | Pubchem ID : | 817704 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 32.93 |
TPSA : | 61.03 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.18 cm/s |
Log Po/w (iLOGP) : | 1.44 |
Log Po/w (XLOGP3) : | -0.17 |
Log Po/w (WLOGP) : | 0.08 |
Log Po/w (MLOGP) : | -0.9 |
Log Po/w (SILICOS-IT) : | 0.2 |
Consensus Log Po/w : | 0.13 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.94 |
Solubility : | 14.5 mg/ml ; 0.116 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.66 |
Solubility : | 27.6 mg/ml ; 0.221 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.38 |
Solubility : | 5.24 mg/ml ; 0.0419 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.8 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With ammonia In ethanol at 130℃; for 12 h; Autoclave | A suspension of 4-chloro-5-methoxypyrimidine (I-89) (40 g, 280 mmol) in NH3 (g)/EtOH (4 M, 2000 mL) was poured into an autoclave at room temperature and stirred at 130 °C for 12 hr. TLC (CH2CI2/MeOH = 10:1 ) showed the reaction was complete. The mixture was cooled to room temperature and concentrated in vacuo to give a residue, to which was added CH2CI2 (100 mL) and the resulting mixture was stirred at room temperature for 30 min. The resulting suspension was filtered to remove NH4CI salt, and the filtrate was concentrated in vacuo to give the crude product. The crude product was stirred in a mixed solvent of EtOAc/CH2CI2 (50 mL, 4:1 ) for 30 min, filtered and concentrated in vacuo to obtain 4-amino-5-methoxypyrimidine (I-90) (30 g, 87percent) as a yellow solid. 1H NMR (400 MHz, DMSO-c/6) 8 ppm 8.01 (s, 1 H), 7.81 (s, 1 H), 6.75 (br. s., 2 H), 3.81 (s, 3 H). |
[ 99979-77-8 ]
2-Chloro-5-methoxypyrimidin-4-amine
Similarity: 0.84
[ 6960-17-4 ]
2,5-Dimethoxypyrimidin-4-amine
Similarity: 0.82
[ 5018-41-7 ]
4-Amino-6-chloro-5-methoxypyrimidine
Similarity: 0.79
[ 99979-77-8 ]
2-Chloro-5-methoxypyrimidin-4-amine
Similarity: 0.84
[ 6960-17-4 ]
2,5-Dimethoxypyrimidin-4-amine
Similarity: 0.82
[ 5018-41-7 ]
4-Amino-6-chloro-5-methoxypyrimidine
Similarity: 0.79
[ 141124-58-5 ]
2,4-diaminopyrimidin-5-ol dihydrochloride
Similarity: 0.77
[ 99979-77-8 ]
2-Chloro-5-methoxypyrimidin-4-amine
Similarity: 0.84
[ 6960-17-4 ]
2,5-Dimethoxypyrimidin-4-amine
Similarity: 0.82
[ 5018-41-7 ]
4-Amino-6-chloro-5-methoxypyrimidine
Similarity: 0.79
[ 141124-58-5 ]
2,4-diaminopyrimidin-5-ol dihydrochloride
Similarity: 0.77